Suppr超能文献

骨髓间充质干细胞抑制佐剂诱导关节炎中的白细胞介素-9。

Bone marrow mesenchymal stem cells suppress IL-9 in adjuvant-induced arthritis.

机构信息

a Zoology Department, Faculty of Women for Arts, Science and Education , Ain Shams University , Cairo , Egypt.

出版信息

Autoimmunity. 2018 Feb;51(1):25-34. doi: 10.1080/08916934.2018.1428956. Epub 2018 Jan 23.

Abstract

Interleukin-9 (IL-9) has been shown to be upregulated in rheumatoid arthritis (RA). The exact role of IL-9 has not yet been effectively studied. Mesenchymal stem cells (MSCs) have shown a promising immunomodulatory role towards repairing cartilage and restoring joint function. One of the key problems influencing the therapeutic efficacy of stem cell therapy is the poor cell survival following transplantation. This is attributed to oxidative and inflammatory stresses at the injured sites. Hesperidin (Hsd), a flavanone present in citrus fruits, has been studied as potential therapeutic agents that have anti-oxidant and anti-inflammatory activities. The objective of this study is to evaluate the therapeutic paracrine action of bone marrow MSCs on the IL-9 level in adjuvant-induced arthritis (AIA) and the enhancement effect of Hsd on transplanted MSCs. Articular tissue inflammation and cartilage damage were assessed by histological scoring. Antinuclear autoantibodies, tumour necrosis factor-alpha (TNF-α), IL-9, IL-4, interferon gamma (IFN-δ), and transforming growth factor-beta1 (TGF-β1), as well as malondialdehyde (MDA), glutathione (GSH), and superoxide dismutase (SOD) levels, were assessed in spleen tissue homogenates after treatment with MSCs either alone or combined with Hsd for 4 weeks in an AIA rat model. Results of this study confirmed that MSCs decreased IL-9 levels in AIA and provide novel insights into the application of Hsd on MSC-based treatments. Highlights Adjuvant-induced arthritis (AIA) is one of the most widely used models that has a great similarity to rheumatoid arthritis (RA). Few studies in recent years have estimated IL-9 in rheumatic diseases and it remains an understudied cytokine. For the first time, bone marrow mesenchymal stem cells (MSCs) therapy has a vital role in splenocytes IL-9 level and further studies are required. Combined therapy of MSCs with antioxidants as hesperidin (Hsd) can alleviate oxidative stress and enhance stem cells immunomodulatory action.

摘要

白细胞介素-9 (IL-9) 在类风湿关节炎 (RA) 中呈上调表达。IL-9 的确切作用尚未得到有效研究。间充质干细胞 (MSCs) 在修复软骨和恢复关节功能方面表现出有希望的免疫调节作用。影响干细胞治疗疗效的一个关键问题是移植后细胞存活率低。这归因于损伤部位的氧化和炎症应激。柚皮苷 (Hsd) 是柑橘类水果中存在的一种黄烷酮,已被研究为具有抗氧化和抗炎活性的潜在治疗剂。本研究的目的是评估骨髓间充质干细胞对佐剂诱导关节炎 (AIA) 中 IL-9 水平的治疗旁分泌作用,以及 Hsd 对移植间充质干细胞的增强作用。通过组织学评分评估关节组织炎症和软骨损伤。在 AIA 大鼠模型中,用 MSCs 单独或与 Hsd 联合治疗 4 周后,评估脾组织匀浆中的抗核自身抗体、肿瘤坏死因子-α (TNF-α)、IL-9、IL-4、干扰素γ (IFN-δ) 和转化生长因子-β1 (TGF-β1) 以及丙二醛 (MDA) 、谷胱甘肽 (GSH) 和超氧化物歧化酶 (SOD) 水平。本研究结果证实 MSCs 降低了 AIA 中的 IL-9 水平,并为 Hsd 在 MSC 为基础的治疗中的应用提供了新的见解。研究亮点 佐剂诱导关节炎 (AIA) 是最广泛使用的模型之一,与类风湿关节炎 (RA) 非常相似。近年来,很少有研究估计风湿性疾病中的 IL-9,它仍然是一种研究不足的细胞因子。骨髓间充质干细胞 (MSCs) 治疗首次在脾细胞 IL-9 水平中发挥重要作用,需要进一步研究。间充质干细胞与抗氧化剂(如柚皮苷)联合治疗可减轻氧化应激,增强干细胞的免疫调节作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验